✦ LIBER ✦

Disposition and metabolism of14C-dovitinib (TKI258), an inhibitor of FGFR and VEGFR, after oral administration in patients with advanced solid tumors

✍ Scribed by Anne-Charlotte Dubbelman, Alana Upthagrove…

Book ID: 120776513
Publisher: Springer
Year: 2012
Tongue: English
Weight: 735 KB
Volume: 70
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-012-1947-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I Study of Dovitinib (TKI258), an

Phase I Study of Dovitinib (TKI258), an Oral FGFR, VEGFR, and PDGFR Inhibitor, in Advanced or Metastatic Renal Cell Carcinoma

✍ Angevin, E.; Lopez-Martin, J. A.; Lin, C.-C.; Gschwend, J. E.; Harzstark, A.; Ca 📂 Article 📅 2013 🏛 American Association for Cancer Research 🌐 English ⚖ 566 KB

597 Pharmacokinetics of the Novel FGFR a

597 Pharmacokinetics of the Novel FGFR and VEGFR Inhibitor, E-3810, in Patients with Advanced Solid Tumors Participating to a Phase I/II Trial

✍ Zangarini, M.; Sala, F.; Camboni, M.G.; Cereda, R.; Livi, V.; Bahleda, R.; Diens 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Characterizing the disposition, metaboli

Characterizing the disposition, metabolism, and excretion of an orally active pan-deacetylase inhibitor, panobinostat, via trace radiolabeled14C material in advanced cancer patients

✍ Clive, Sally; Woo, Margaret M.; Nydam, Thomas; Kelly, Lindsay; Squier, Margaret; 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 417 KB

Phase I and pharmacokinetic study of sor

Phase I and pharmacokinetic study of sorafenib, an oral multikinase inhibitor, in Japanese patients with advanced refractory solid tumors

✍ Hironobu Minami; Kenji Kawada; Hiromichi Ebi; Koichi Kitagawa; Yon-il Kim; Kazuh 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

72 POSTER Phase I, safety, pharmacokinet

72 POSTER Phase I, safety, pharmacokinetic and biomarker study of telatinib (BAY 57-9352), an oral VEGFR-2 inhibitor, in a continuous schedule in patients with advanced solid tumors

✍ H. Gelderblom; J. Verweij; N. Steeghs; E. de Koning; A. van Erkel; L. van Doorn; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Effect of food and a proton pump inhibit

Effect of food and a proton pump inhibitor on the pharmacokinetics of S-1 following oral administration of S-1 in patients with advanced solid tumors

✍ Max E. Scheulen; Kaku Saito; Ralf A. Hilger; Bastian Mende; Christopher Zergebel 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 371 KB